Advertisement

Topics

Arlington Capital Partners Announces Majority Investment in Grand River Aseptic Manufacturing

12:51 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Arlington Capital Partners (“Arlington”), a Washington, DC-area private equity firm, today announced a majority investment in Grand River Aseptic Manufacturing (“GRAM” or the “Company”). Based in Grand Rapids, MI, GR...

Other Sources for this Article

Arlington Capital Partners
Matthew Altman
5425 Wisconsin Avenue, Suite 200
Chevy Chase, MD 20815
202-337-7500

NEXT ARTICLE

More From BioPortfolio on "Arlington Capital Partners Announces Majority Investment in Grand River Aseptic Manufacturing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...